RAFAEL HOLDINGS, INC. Revenue from Contract with Customer, Excluding Assessed Tax
RAFAEL HOLDINGS, INC. (RFL) reported Revenue from Contract with Customer, Excluding Assessed Tax of $30.00 thousand for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-10-29
- RAFAEL HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $30.00K.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|
| 2025-07-31 | $30.00K 10-K · filed 2025-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |